Marco Santoro

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

Carmen Fava, Giovanna Rege‐Cambrin, Irene Dogliotti et al. · Haematologica · 2019 · 77 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study

Sergio Siragusa, Alessandra Malato, Giorgia Saccullo et al. · American Journal of Hematology · 2011 · 65 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

The New HFA/ICOS Risk Assessment Tool to Identify Patients with Chronic Myeloid Leukaemia at High Risk of Cardiotoxicity

Daniela Di Lisi, Cristina Madaudo, Giulia Alagna et al. · ESC Heart Failure · 2022 · 37 citations · Full text

Medicine, Cardiology, Oncology +17

Cancer patients requiring interruption of long‐term warfarin because of surgery or chemotherapy induced thrombocytopenia: The use of fixed sub‐therapeutic doses of low‐molecular weight heparin

Giorgia Saccullo, Alessandra Malato, Simona Raso et al. · American Journal of Hematology · 2012 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?

Salvatrice Mancuso, Marco Santoro, Vincenzo Accurso et al. · Oncology Research and Treatment · 2020 · 24 citations

Medicine, Hematology, Clinical Cardiology +16